• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压对二尖瓣反流患者经导管边缘对边缘修复术后结局的影响。

Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation.

作者信息

Jaeger Philippa, Toskas Ioannis, Henes Jessica-Kristin, Shcherbyna Serhii, Schwarz Frederic, Euper Miriam, Seizer Peter, Langer Harald, May Andreas E, Geisler Tobias, Gawaz Meinrad, Schreieck Jürgen, Rath Dominik

机构信息

Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.

Departmen of Cardiology and Angiology, Ostalb-Klinikum, Aalen, Germany.

出版信息

Clin Res Cardiol. 2025 Feb;114(2):203-214. doi: 10.1007/s00392-024-02442-1. Epub 2024 Apr 2.

DOI:10.1007/s00392-024-02442-1
PMID:38565712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11839688/
Abstract

AIM

Data on associations of invasively determined hemodynamic parameters with procedural success and outcomes in patients suffering from mitral regurgitation (MR) undergoing transcatheter edge-to-edge repair of the mitral valve (M-TEER) is limited.

METHODS AND RESULTS

We enrolled 239 patients with symptomatic MR of grade 2 + , who received M-TEER. All patients underwent extensive pre-interventional invasive hemodynamic measurements via right heart catheterization (mean pulmonary arterial pressure (mPAP), systolic- (PAPsys) and diastolic pulmonary arterial pressure (PAPdia), pulmonary arterial wedge pressure (PAWP), a-wave, v-wave, pulmonary vascular resistance (PVR), transpulmonary pressure gradient (TPG), cardiac index (CI), stroke volume index (SVI)). mPAP and PAWP at baseline were neither associated with procedural success, immediate reduction of MR, nor residual MR after 6 months of follow-up. The composite outcome (All-cause mortality (ACM) and/or heart failure induced rehospitalization (HFH)) and HFH differed significantly after M-TEER when stratified according to mPAP, PAWP, PAPdia, a-wave and v-wave. ACM was not associated with the afore mentioned parameters. Neither PVR, TPG, CI nor SVI were associated with the composite outcome and HFH, respectively. In multivariable analyses, PAWP was independently associated with the composite outcome and HFH. PVR and SVI were not associated with outcomes.

CONCLUSION

PAWP at baseline was significantly and independently associated with HFH and might serve as a valuable parameter for identifying patients at high risk for HFH after M-TEER. ACM and procedural success were not affected by pulmonary arterial pressure before M-TEER. We suggest that the post-capillary component of PH serves as the driving force behind the risk of HFH.

摘要

目的

关于二尖瓣反流(MR)患者在接受经导管二尖瓣缘对缘修复术(M-TEER)时,有创测定的血流动力学参数与手术成功率及预后之间关联的数据有限。

方法与结果

我们纳入了239例症状性2+级及以上MR患者,他们接受了M-TEER。所有患者均通过右心导管检查进行了广泛的介入前有创血流动力学测量(平均肺动脉压(mPAP)、收缩期肺动脉压(PAPsys)和舒张期肺动脉压(PAPdia)、肺动脉楔压(PAWP)、a波、v波、肺血管阻力(PVR)、跨肺压梯度(TPG)、心脏指数(CI)、每搏量指数(SVI))。基线时的mPAP和PAWP与手术成功率、MR的即刻降低以及随访6个月后的残余MR均无关联。根据mPAP、PAWP、PAPdia、a波和v波进行分层后,M-TEER后的复合结局(全因死亡率(ACM)和/或心力衰竭导致的再次住院(HFH))以及HFH有显著差异。ACM与上述参数无关。PVR、TPG、CI和SVI分别与复合结局和HFH均无关联。在多变量分析中,PAWP与复合结局和HFH独立相关。PVR和SVI与结局无关。

结论

基线时的PAWP与HFH显著且独立相关,可能是识别M-TEER后HFH高危患者的一个有价值参数。ACM和手术成功率不受M-TEER前肺动脉压的影响。我们认为,PH的毛细血管后成分是HFH风险背后的驱动力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/b10c3a70dd86/392_2024_2442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/3443146f6e4a/392_2024_2442_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/668ae2c37d76/392_2024_2442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/0cb90bb08988/392_2024_2442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/b10c3a70dd86/392_2024_2442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/3443146f6e4a/392_2024_2442_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/668ae2c37d76/392_2024_2442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/0cb90bb08988/392_2024_2442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f4/11839688/b10c3a70dd86/392_2024_2442_Fig4_HTML.jpg

相似文献

1
Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation.肺动脉高压对二尖瓣反流患者经导管边缘对边缘修复术后结局的影响。
Clin Res Cardiol. 2025 Feb;114(2):203-214. doi: 10.1007/s00392-024-02442-1. Epub 2024 Apr 2.
2
Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.肺动脉高压与二尖瓣缘对缘修复术后患者结局的相关性。
Heart. 2024 May 10;110(11):800-807. doi: 10.1136/heartjnl-2023-323473.
3
Impact of Updated Invasive Right Ventricular and Pulmonary Hemodynamics on Long-Term Outcomes in Patients With Mitral Valve Transcatheter Edge-to-Edge Repair.更新的有创右心室和肺血流动力学对二尖瓣经导管缘对缘修复患者长期预后的影响
Am J Cardiol. 2025 Jan 1;234:99-106. doi: 10.1016/j.amjcard.2024.11.010. Epub 2024 Nov 21.
4
Impact of right ventricular-to-pulmonary artery coupling on remodeling and outcome in patients undergoing transcatheter edge-to-edge mitral valve repair.右心室-肺动脉耦联对接受经导管二尖瓣缘对缘修复术患者的重塑及预后的影响
Clin Res Cardiol. 2025 Feb;114(2):156-167. doi: 10.1007/s00392-023-02318-w. Epub 2023 Oct 23.
5
Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair: The COAPT Trial.经导管缘对缘修复术后重复二尖瓣瓣叶干预:COAPT 试验。
Am J Cardiol. 2024 Jul 15;223:7-14. doi: 10.1016/j.amjcard.2024.05.025. Epub 2024 May 23.
6
Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.左心房改善在伴有继发性二尖瓣反流和心力衰竭的患者中:COAPT 试验。
JACC Cardiovasc Imaging. 2024 Sep;17(9):1015-1027. doi: 10.1016/j.jcmg.2024.03.016. Epub 2024 May 22.
7
Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair: A Multicenter Experience.经导管缘对缘修复失败后经心尖经导管二尖瓣置换术:一项多中心经验
JACC Cardiovasc Interv. 2025 Feb 10;18(3):311-321. doi: 10.1016/j.jcin.2024.10.018.
8
Mismatch Between Residual Mitral Regurgitation and Left Atrial Pressure Predicts Prognosis After Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术后残余二尖瓣反流与左心房压力不匹配预测预后。
JACC Cardiovasc Interv. 2024 Sep 23;17(18):2126-2137. doi: 10.1016/j.jcin.2024.07.046.
9
Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study.心力衰竭住院对二尖瓣经导管缘对缘修复术后临床结局的影响:EXPAND 研究结果。
Eur J Heart Fail. 2024 Jul;26(7):1495-1503. doi: 10.1002/ejhf.3250. Epub 2024 May 10.
10
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry.缘对缘修复二尖瓣反流的长期结果:EuroSMR 注册研究的 5 年结果。
JACC Cardiovasc Interv. 2024 Nov 11;17(21):2543-2554. doi: 10.1016/j.jcin.2024.08.016.

引用本文的文献

1
The impact of pulmonary hypertension on prognosis in moderate-to-severe mitral regurgitation patients treated with transcatheter edge-to-edge mitral valve repair: a comprehensive meta-analysis.肺动脉高压对经导管二尖瓣缘对缘修复术治疗的中重度二尖瓣反流患者预后的影响:一项综合荟萃分析。
Front Cardiovasc Med. 2025 Jan 10;11:1489674. doi: 10.3389/fcvm.2024.1489674. eCollection 2024.

本文引用的文献

1
Deceleration capacity of heart rate predicts 1-year mortality in patients undergoing transcatheter edge-to-edge mitral valve repair.心率减速能力可预测行经皮缘对缘二尖瓣修复术患者的 1 年死亡率。
Clin Cardiol. 2023 May;46(5):529-534. doi: 10.1002/clc.24007. Epub 2023 Mar 22.
2
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
3
Change in Invasively Measured Mean Pulmonary Artery Pressure After Transcatheter Mitral Valve Repair Is Associated With Heart Failure Readmission.
经导管二尖瓣修复术后有创测量的平均肺动脉压变化与心力衰竭再入院相关。
Cardiol Res. 2021 Oct;12(5):302-308. doi: 10.14740/cr1284. Epub 2021 Jul 28.
4
Haemodynamic impact of MitraClip in patients with functional mitral regurgitation and pulmonary hypertension.MitraClip对功能性二尖瓣反流合并肺动脉高压患者的血流动力学影响。
Eur J Clin Invest. 2021 Dec;51(12):e13676. doi: 10.1111/eci.13676. Epub 2021 Sep 21.
5
Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure.既往心力衰竭住院史在因慢性心力衰竭恶化而住院患者中的预后作用
Circ Heart Fail. 2021 Apr;14(4):e007871. doi: 10.1161/CIRCHEARTFAILURE.120.007871. Epub 2021 Mar 29.
6
Basic Principles of the Echocardiographic Evaluation of Mitral Regurgitation.二尖瓣反流的超声心动图评估的基本原则。
JACC Cardiovasc Imaging. 2021 Apr;14(4):843-853. doi: 10.1016/j.jcmg.2020.06.049. Epub 2021 Jan 13.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
8
Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.经导管二尖瓣修复术治疗继发性二尖瓣反流相关肺动脉高压:COAPT 试验。
J Am Coll Cardiol. 2020 Dec 1;76(22):2595-2606. doi: 10.1016/j.jacc.2020.09.609.
9
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair.肺动脉高压与经导管二尖瓣修复术临床结局的相关性。
JAMA Cardiol. 2020 Jan 1;5(1):47-56. doi: 10.1001/jamacardio.2019.4428.
10
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.